News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
257,350 Results
Type
Article (8926)
Company Profile (34)
Press Release (248390)
Multimedia
Podcasts (4)
Webinars (9)
Section
Business (74782)
Career Advice (911)
Deals (13716)
Drug Delivery (18)
Drug Development (28431)
Employer Resources (100)
FDA (6063)
Job Trends (6072)
News (126113)
Policy (12168)
Tag
Academia (1259)
Accelerated approval (2)
Adcomms (4)
Allergies (41)
Alliances (22075)
ALS (45)
Alzheimer's disease (605)
Antibody-drug conjugate (ADC) (27)
Approvals (6097)
Artificial intelligence (90)
Autoimmune disease (5)
Automation (7)
Bankruptcy (63)
Best Places to Work (5247)
BIOSECURE Act (5)
Biosimilars (28)
Biotechnology (28)
Bladder cancer (36)
Brain cancer (12)
Breast cancer (102)
Cancer (878)
Cardiovascular disease (43)
Career advice (775)
Career pathing (22)
CAR-T (35)
Cell therapy (138)
Cervical cancer (7)
Clinical research (23698)
Collaboration (354)
Compensation (210)
Complete response letters (9)
COVID-19 (849)
CRISPR (18)
C-suite (105)
Cystic fibrosis (31)
Data (971)
Decentralized trials (2)
Denatured (1)
Depression (8)
Diabetes (71)
Diagnostics (2307)
Digital health (11)
Diversity (3)
Diversity, equity & inclusion (25)
Drug discovery (42)
Drug pricing (12)
Drug shortages (2)
Duchenne muscular dystrophy (63)
Earnings (26445)
Editorial (12)
Employer branding (13)
Employer resources (87)
Events (41274)
Executive appointments (305)
FDA (6683)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (285)
Gene editing (38)
Generative AI (7)
Gene therapy (130)
GLP-1 (167)
Government (1905)
Grass and pollen (3)
Guidances (75)
Healthcare (9558)
Huntington's disease (5)
IgA nephropathy (14)
Immunology and inflammation (16)
Indications (11)
Infectious disease (899)
Inflammatory bowel disease (47)
Inflation Reduction Act (2)
Influenza (18)
Intellectual property (35)
Interviews (182)
IPO (6484)
IRA (5)
Job creations (1043)
Job search strategy (646)
Kidney cancer (7)
Labor market (9)
Layoffs (54)
Leadership (14)
Legal (2302)
Liver cancer (32)
Lung cancer (113)
Lymphoma (57)
Management (33)
Manufacturing (111)
MASH (19)
Medical device (4925)
Medtech (4928)
Mergers & acquisitions (7579)
Metabolic disorders (170)
Multiple sclerosis (32)
NASH (2)
Neurodegenerative disease (29)
Neuropsychiatric disorders (3)
Neuroscience (810)
NextGen: Class of 2025 (2950)
Non-profit (3380)
Now hiring (2)
Obesity (73)
Opinion (70)
Ovarian cancer (28)
Pain (24)
Pancreatic cancer (35)
Parkinson's disease (56)
Partnered (11)
Patents (70)
Patient recruitment (51)
Peanut (21)
People (22091)
Pharmaceutical (15)
Pharmacy benefit managers (5)
Phase I (6948)
Phase II (10190)
Phase III (8514)
Pipeline (537)
Policy (30)
Postmarket research (767)
Preclinical (2769)
Press Release (29)
Prostate cancer (42)
Psychedelics (2)
Radiopharmaceuticals (131)
Rare diseases (164)
Real estate (2582)
Recruiting (40)
Regulatory (8833)
Reports (20)
Research institute (1074)
Resumes & cover letters (129)
Rett syndrome (5)
RSV (11)
Schizophrenia (23)
Series A (43)
Series B (28)
Service/supplier (2)
Sickle cell disease (24)
Special edition (1)
Spinal muscular atrophy (65)
Sponsored (14)
Startups (1205)
Stomach cancer (3)
Supply chain (27)
Tariffs (5)
The Weekly (3)
Vaccines (180)
Venture capitalists (6)
Weight loss (23)
Women's health (5)
Worklife (12)
Date
Today (69)
Last 7 days (374)
Last 30 days (1245)
Last 365 days (12843)
2025 (4650)
2024 (14079)
2023 (17069)
2022 (22569)
2021 (24456)
2020 (24666)
2019 (21766)
2018 (16094)
2017 (12628)
2016 (11562)
2015 (13962)
2014 (9461)
2013 (7480)
2012 (7838)
2011 (8285)
2010 (6951)
Location
Africa (325)
Alabama (11)
Alaska (6)
Arizona (53)
Arkansas (5)
Asia (26565)
Australia (3790)
California (2384)
Canada (820)
China (236)
Colorado (66)
Connecticut (94)
Delaware (26)
Europe (41288)
Florida (339)
Georgia (48)
Idaho (24)
Illinois (229)
India (18)
Indiana (130)
Iowa (5)
Japan (113)
Kansas (34)
Kentucky (15)
Louisiana (8)
Maine (26)
Maryland (340)
Massachusetts (1926)
Michigan (45)
Minnesota (117)
Mississippi (1)
Missouri (32)
Montana (2)
Nebraska (11)
Nevada (16)
New Hampshire (14)
New Jersey (796)
New Mexico (4)
New York (717)
North Carolina (364)
North Dakota (5)
Northern California (992)
Ohio (94)
Oklahoma (5)
Oregon (8)
Pennsylvania (546)
Puerto Rico (9)
Rhode Island (14)
South America (418)
South Carolina (14)
Southern California (984)
Tennessee (52)
Texas (321)
United States (9070)
Utah (54)
Virginia (79)
Washington D.C. (25)
Washington State (210)
West Virginia (3)
Wisconsin (22)
257,350 Results for "cactus communications pvt ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Antibodies.com and Cactus Communications Partner to Accelerate Life Science Manuscript Publication
February 6, 2025
·
2 min read
Press Releases
Resilience Partners with Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD
January 8, 2025
·
3 min read
BioMidwest
Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University
Rafarma Pharmaceuticals - We are pleased to announce that Rapharma and its CEO Raivo Unt have entered into a preliminary agreement with Kelun Lifesciences Ltd, a pharmaceutical company based in Sri Lanka, on 17 November 2023.
December 11, 2023
·
3 min read
Business
ValGenesis and Life Science Consulting Pvt. Ltd. Form Partnership to Enhance Quality and Compliance for Life Sciences Companies Across North America, Europe, and Asia
ValGenesis, Inc. and Life Science Consulting Pvt. Ltd. have partnered to provide best-in-class digital validation solutions to enhance compliance and quality across life sciences disciplines such as production, quality control and assurance, information technology, and research and development.
May 30, 2023
·
3 min read
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
April 23, 2025
·
1 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
Press Releases
Hanx Biopharmaceuticals, Ltd. Showcases Five Innovative Cancer Therapies at 2025 AACR Annual Meeting
May 7, 2025
·
2 min read
Cancer Stem Cells Market to Reach USD 4.5 Billion to 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
According to the latest research by InsightAce Analytic, the Global Cancer Stem Cells Market is valued at US$ 2.1 Bn in 2023, and it is expected to reach US$ 4.5 Bn by 2031, with a CAGR of 9.7% during the forecast period of 2024-2031.
May 17, 2024
·
1 min read
1 of 25,735
Next
